CONTEXT AND OBJECTIVE: Worldwide, there is no single strategy for optimal management of patients with ASCUS (atypical squamous cells of undetermined significance) cytology reports. The objective of this study was to determine the kind of clinical management conducted among women with a first ASCUS Pap smear report. DESIGN AND SETTING: Prospective single cohort study at a cervical pathology unit in Santiago, Chile.
INTRODUCTION

Atypical squamous cells of undetermined significance (ASCUS)
are the most prevalent abnormality in cervical cytological evaluations. This is a category of uncertain morphology and is at the limit between normal and abnormal cytological interpretations. 1, 2 The clinical significance of ASCUS is considered to be indeterminate, which means that there is controversy or debate regarding its clinical management, given that there is no single choice for optimal treatment. 3, 4 In Chile, the Ministry of Health (Minsal) has developed clinical guidelines that contain two clinical decision diagrams called the "algorithm for conveying the first atypical Pap test according to Bethesda 2001 classification, to a specialist or cervical pathology unit (CPU)" and the "algorithm for diagnostic confirmation". 5, 6 These diagrams contain the steps for diagnostic confirmation and treatment of cervical atypia and are based on the first consensus guidelines for management of these cervical atypia, published by Wright et al., 7 which were based on the multicenter study titled Atypical Squamous Cells of Undetermined
Significance/Low-grade Squamous Intraepithelial Lesion Triage Study (ALTS). 8 In Chile there is a paucity of scientific evidence on the clinical management of women with cervical atypia. 9 In addition, the national conveyance algorithm and national diagnostic confirmation algorithm are supported by evidence derived from English-speaking countries. [10] [11] [12] [13] This situation makes it appropriate and relevant to conduct studies that generate current and local epidemiological evidence for managing atypical cervical cytology. This challenge is consistent with the objectives set by
Minsal, which has the goal of generating clinical algorithms supported by national scientific evidence.
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OBJECTIVE
The objective of this study was to determine the kind of clinical management performed among females with a first ASCUS System (a cytological-histological database). At this time, all the ASCUS reports were selected (n = 555) ( Table 1) .
Selection criteria were applied to these patients, so as to select patients without previous uterine pathological conditions, without previous cervical procedures and with normal Pap results over a three-year period prior to the beginning of the study.
After making this selection, a cohort of 446 women with ASCUS reports was obtained and these women were monitored for a period of three years, or until resolution of the case or until loss from the follow up. They were treated at the Cervical Pathology
Unit of the Barros Luco Hospital.
For data gathering, the Cyto-Expert database and the patient's clinical records were used.
The variables studied included the women's ages at the time when ASCUS was identified; the type and number of cytological, colposcopic and histological results; and treatments instituted. The following definitions were used in coding the col- 
RESULTS
The study population consisted of 446 women with ASCUS cytology reports. The average age of the women was 37.74 years, with a minimum age of 17 and maximum age of 88. The clinical management performed was based on the national clinical algorithms.
The follow-up was presented in five phases: screening, diagnosis, diagnostic confirmation, treatment and post-treatment evaluation.
In the first phase (screening), 92,001 Pap tests were collected.
A result consisting of ASCUS was found in 0.60% of this population (n = 555) ( Table 1) . A cohort of 446 women was obtained from this group by applying the selection criteria of our study. In most of the women, negative colposcopic findings (n = 13) were correlated with negative histological findings. The result was confirmed in the cases of seven women (negative for cervical intraepithelial neoplasia) and two others were found to have CIN 1. HPV was present in the remaining four women (Figure 2 ).
Among the patients diagnosed with IEL (n = 39), the colposcopic results coincided with the histological results in 33 cases, and these results were: CIN 1 (n = 9), CIN 2 (n = 14), CIN 3 (n = 9) and CIS (n = 1). The remaining six were negative for intraepithelial neoplasia (Neg).
The patients diagnosed with squamous cell carcinoma (n = 2) were confirmed histologically to have stage IB2 cervical cancer (SCC).
The patients whose colposcopy was defined as Neg + HPV (n = 5) received confirmation of the presence of HPV from the histological result.
Finally, the cases of undetermined colposcopic findings (n = 3)
were defined by means of histological examinations, such that two cases were negative for lesions (Neg) and one presented CIN 1.
In summary, the results from the 58 biopsies performed were Neg, negative for intraepithelial lesion; IEL, intraepithelial neoplasia; HPV, human papillomavirus; SCC, squamous cell carcinoma; CIN 1, mild cervical intraepithelial neoplasia; CIN 2, moderate cervical intraepithelial neoplasia; CIN 3, severe cervical intraepithelial neoplasia; CIS, carcinoma "in situ".
In addition, a general physical and gynecological examination was performed. These procedures were carried out over a period of approximately three years, which was a requirement in order to discharge the patients from the algorithm and to return them to their corresponding PHC. 
DISCUSSION
Debate continues regarding what the single strategy for optimal management of patients with ASCUS cytological reports might be. [1] [2] [3] In our study, the population affected by this uncertain situation had a wide age range (17-88 years), which exceeded the limits (25-64 years) of the National Cervical Cancer Program.
However, our age ranges were similar to those in Iraq, the United
States and Turkey, in that the ages of females with a first atypical Pap result go from adolescence to adulthood. [17] [18] [19] The clinical management strategies for these women, i.e.
those for whom referral to specialists or a Cervical Pathology Unit for first atypical Pap results is proposed by the algorithm, in accordance with the Bethesda 2001 classification, are outlined in the National Clinical Guidelines. 6 At the diagnosis stage, the ASCUS cytological report is repeated, as indicated in our National
Guidelines. This is also highly recommendable and advisable according to the various clinical guidelines of some other countries such as the United States, France and England. 1, 12, 13, 20 of whom presented CIN 2+ lesions. 20 However, other studies have indicated that immediate colposcopy should only be performed on HSIL+ lesions, given that minor lesions return spontaneously. 24 We recommend that colposcopy should only be performed when there are two consecutive atypical Pap tests, because with these two results, we were able to demonstrate 85.5% of the lesions, whereas colposcopy performed immediately after the first atypical Pap test only showed 16.9% of the lesions.
An exploratory colposcopy examination is considered, within the algorithm, to be a procedure that would allow a decision to carry out a directed biopsy. 6 Although the standards do not establish any necessity for a biopsy in cases of negative results, this was carried out in the majority of our cases (9 out of 13) and yielded two cases of a minor lesion (CIN 1). In cases of inconclusive results, a biopsy was also performed, yielding the following:
Neg (n = 2) and CIN 2 (n = 1).
The diagnostic confirmation stage was followed by the treatment stage, which was conducted in accordance with the literature.
Lastly, the follow-up was conducted on 363 cases in our cohort of women with a first ASCUS report. The 83 cases that were lost from the follow-up were not taken into consideration. The women who returned for follow-up evaluation presented a LSIL rate of 3.6% and a HSIL rate of 11.6%, both of which are within the range of results from other studies over the last five years, from 0% to 47.1% for LSIL and 0.8% to 8.6% for HSIL. 17, 18, 25, 26 It is clear that the percentage of HSIL lesions was higher than in the literature, but the cause is hard to explain. The diagnostic confirmation of these lesions was achieved by completion of a biopsy. This procedure was the same as has been established in the scientific literature, which considers that the efficiency of cervical cytological screening is determined through histological verification. 19 These procedures that have been established through algorithms possess strengths and weaknesses. We consider that their strength lies in the contribution that they have made towards resultant lower rates of cervical cancer mortality in Chile.
We consider that the lack of classification of the HPV virus is a weakness, given that there are no studies to support the algorithm regarding HPV.
These algorithm-guided behaviors have contributed towards lower rates of cervical cancer mortality in Chile, which are among the lowest in Latin America. Neg, negative for intraepithelial lesion; CIN, cervical intraepithelial neoplasia; HPV, human papillomavirus; CIN 1, mild cervical intraepithelial neoplasia; CIN 2, moderate cervical intraepithelial neoplasia; CIN 3, severe cervical intraepithelial neoplasia; SCC, squamous cell carcinoma.
CONCLUSIONS
The clinical management observed through our monitoring
shows that cases of a first ASCUS cytological report are managed in a traditional manner, in that it takes into consideration screening, diagnosis, diagnostic confirmation, treatment and posttreatment evaluation stages. We agree with repetition of the first atypical Pap test six months later because this enables definition of the results.
The rate of regression to normality among the ASCUS cases was 85.1%, which confirms that Pap tests should only be repeated as part of the surveillance pattern.
We agree that women should be sent for immediate colposcopy whenever there are two consecutive atypical results, because of the high percentage of lesions (85.5%).
